Phylo

Phylo is an applied research lab building agentic intelligence to accelerate discovery for every biomedical scientist. Founded by Stanford PhD researchers who built the first biology agent (CRISPR-GPT) and the first general-purpose biomedical agent (Biomni), Phylo is pioneering the next generation of AI systems for the life sciences.

The company believes AI agents will fundamentally transform how biomedical research is done, enabling faster and more systematic scientific progress. Phylo's platform is already used by thousands of organizations globally, including ~20 enterprise accounts across top-20 pharma and large biotech companies, with scientists like Feng Zhang actively utilizing the system.

Backed by a $13.5M seed round led by a16z, Menlo Ventures, and Anthropic, and advised by Nobel Prize laureates and pioneering biologists including Feng Zhang, Caroline Bartoszek, and Fabian Theis, Phylo brings together world-class researchers and engineers across AI and biology. Scientific co-founders include Yuri Leskovec and Le Cong, pioneers in AI and CRISPR respectively.

Phylo operates with a culture of excellence and speed — the team moves fast, thinks big, and supports each other. As an early-stage company with a flat organizational structure, every team member has outsized impact on the product and mission to 100X biomedical discoveries through AI.